What’s the Real Cost of Pre-Clinical Research Delays?

Ensuring that new products get to market is a top priority for R&D teams, as delays can significantly impact ROI. But the actual cost of pre-clinical research delays comes from studies that must be repeated due to incorrect testing. iFyber President, Greg Mouchka, offers insights on how to avoid these expensive mistakes. Challenges in Pre-Clinical…
Read More

Medical Device Testing: Strategies for the Best Regimen

All medical device manufacturers strive to ensure devices and biomedical technologies are safe, efficacious, and fit for intended use. The biggest roadblock to accomplishing this is medical device testing to determine the most appropriate regimen for the device and its use. Although speed to market is key, medical device manufacturers must devise and implement an…
Read More

7th Bioengineering and Translational Medicine Conference

iFyber participates in the 7th Bioengineering and Translational Medicine Conference in Boston from Wednesday, December 14, 2022 to Friday, December 16, 2022. The selection of suitable cell populations is crucial to the outcome of regenerative medicine. As a potential stem cell source, teeth are easily accessible, harbor several different cell populations, and yield rapidly growing…
Read More

SAWC Fall 2022

iFyber is looking forward to talking with our wound care researcher friends this coming weekend in Las Vegas! Stop by and meet the team at booth 334.
Read More